The move has been made in response to growing demand for high-quality medical packaging. Credit: Coveris.

Global packaging solution provider Coveris has announced an investment to increase the production capacity for medical device packaging at its sites in Rohrdorf and Halle, Germany.  

In the coming months, the company is investing more than €8m ($8.62m) to upgrade and expand its medical device production lines, thereby responding to the increasing demand for high-quality medical packaging solutions. 

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Coveris plans to install two new pouch lines and one header bag line by late 2024 at its Rohrdorf site. 

The new pouch and bag lines are said to be technologically similar to the existing capabilities at the facility and will improve service.

The Rohrdorf facility, operational since May 2021, is claimed to comply with the highest medical packaging production requirements, including ISO Class 7 certification.  

Meanwhile, Coveris will add a new cast extrusion line at the Halle site to bolster its medical packaging capacity. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Halle site is expected to commence commercial production with the new extrusion line at the beginning of 2025. 

Coveris CEO Christian Kolarik said: “We are investing in site upgrades to further strengthen our medical segment and continue answering growing customer needs for high-performance medical packaging. A clean and safe production environment is extremely important for this sector, but sustainability is also key.  

“The new cast line supports the development of innovative monomaterial-based, recyclable and sustainable flexible packaging solutions for the medical industry. Additionally, both facilities are functioning with our No Waste strategy in mind, operating on electricity from renewable resources.” 

Last month, Coveris announced an expansion of its barrier film capabilities with an investment in vacuum skin packaging production.